Therefore, immunotherapy-based approaches have been considered potential treatments for T1DM in children since they can regulate the autoimmune responses and enhance the children’s quality of life by reducing their daily dose intake of insulin. The gene discussed is INS; the disease is type 1 diabetes mellitus.